ClearOne is trading at $7.15 (94% up) after a majority shareholder approved the issuance of 12.5 million new shares for its planned merger with Cortigent, Inc.
- The share issuance marks a significant corporate milestone, representing a change of control for the company.
- The approval has triggered intense pre-market interest and a sharp re-pricing of shares as investors react to the forthcoming combination with Cortigent.